Solicitation
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
75A50126R00001_RFP_NPIVS_27
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).
Offers due
November 20, 2026 at 5:00 PM EST
19 days from now. Posted October 26, 2026, first published August 17, 2026.
Get an email when this is amended, when the deadline moves and when it is awarded.Watch it
Next from this buyer
- Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture DetectionSources soughtNAICS 334510Anywhere in the USBARDA-FY27-10192026Closes in 17 daysNov 18
- BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)SolicitationNAICS 541714Anywhere in the USDRIVeEZBAA22100SOL00003Closes in 351 daysOct 18, 2027
Similar, open now
- ARPA-H Emerging Health Innovators (EHI) Initiative
National Institutes of Health, Advanced Research Projects Agency for Health (Arpa-H)
SolicitationNAICS 541714District of ColumbiaARPA-H-SOL-26-150Closes in 101 daysFeb 10, 2027 - BROAD AGENCY ANNOUNCEMENT - BIOMEDICAL RESEARCH AND DIVING EQUIPMENT DEVELOPMENT
Department of the Navy, NAVSEA HQ
SolicitationNAICS 541714District of ColumbiaN0002427S0001Closes in 394 daysNov 30, 2027 - Development/Production - Kidney GEC-Specific AAV Vector
Department of Veterans Affairs, Rpo East
Sources soughtNAICS 541714Columbia, MO36C24E27Q0009Closes in 3 daysNov 4
All 17 open in research and development in biotechnology (except nanobiotechnology)
Description
As published on SAM.gov.
BARDA seeks Contractor(s) to support the continuation of the Vaccine Medical Counermeasures (MCM's) for Pandemic Influenza Preparedness and Response Program. Contractors will furnish all the necessary services, qualified personnel, materials, supplies, equipment and facilities (U.S. facilities preferred) not otherwise provided by the USG as needed to provide MCMs, such as vaccines, antigens, and adjuvants, for pandemic preparedness and response or as required in response to a public health emergency; produce antigen and vaccines against influenza virus or other viruses with pandemic potential as required by BARDA; produce antigens, adjuvants, and/or vaccines to support USG efforts to further improve influenza vaccines (for which feasibility data is available); and support rapid regulatory decisions and manufacturing readiness by generating and submitting to FDA all relevant data (e.g., analytical, nonclinical, clinical, and/or chemistry, manufacturing, and controls (CMC)), including data generated during interpandemic periods.
Mandatory Qualification Requirements:
To be eligible for award, the Offeror must produce vaccines against influenza and influenza strains with pandemic potential; must demonstrate a successful experience in the manufacturing of influenza vaccine by:
1. Holding a U.S. influenza vaccine license; or
2. Have developed an influenza vaccine as evidenced by:
a. Submission of a Biologics License Application (BLA) for seasonal or pandemic influenza vaccine
Please see full solicitation details and proposal submission instructions detailed in attachments 01-21 of this notice.
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- 01-75A50126R00001_RFP_Final.pdf1.2 MB, August 17, 2026
- 02-75A50126R00001_RFP Att 1 Prod Handling Guidance Don Nat.pdf62 KB, August 17, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
August 17, 2026
Solicitation, originally presolicitation
Request of Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Due October 30, 2026 at 5:00 PM EDT. SAM.gov, notice 2e4d29dade93498da98c07dacb2374e6
4 revisions on SAM
- September 11, 2026: publish, solicitation
- July 31, 2026: publish, presolicitation
- August 17, 2026: publish, solicitation
- August 17, 2026: publish, solicitation
August 17, 2026
Solicitation
Due October 30, 2026 at 5:00 PM EDT. SAM.gov, notice 38ae60ea2cb04f5d8d14713946892925
4 revisions on SAM
- September 11, 2026: publish, solicitation
- July 31, 2026: publish, presolicitation
- August 17, 2026: publish, solicitation
- August 17, 2026: publish, solicitation
September 11, 2026
Solicitation
Due November 20, 2026 at 5:00 PM EST. SAM.gov, notice d547606225884278817f5008d9a07e99
4 revisions on SAM
- September 11, 2026: publish, solicitation
- July 31, 2026: publish, presolicitation
- August 17, 2026: publish, solicitation
- August 17, 2026: publish, solicitation
October 26, 2026
Solicitation
Due November 20, 2026 at 5:00 PM EST. SAM.gov, notice a63ab723a93d4ac5952e6b64222262ab
5 revisions on SAM
- October 26, 2026: publish, solicitation
- September 11, 2026: publish, solicitation
- July 31, 2026: publish, presolicitation
- August 17, 2026: publish, solicitation
- August 17, 2026: publish, solicitation
Points of contact
- Laura SaddisonLaura.Saddison@hhs.gov